The Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc.

An expert discusses how medical professionals have integrated tagraxofusp into blastic plasmacytoid dendritic cell neoplasm (BPDCN) treatment, leveraging its CD123-targeted efficacy per 0114 trial ...

Marlise R. Luskin, MD, MSCE, discussed treatment options for blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare and challenging disease.

Researchers have uncovered critical mechanisms linked to metabolic insufficiencies that underlie plasmacytoid dendritic cell ...

Mattamy Homes, the largest privately owned homebuilder in North America, is pleased to announce the acquisition of 4.1 acres of prime real estate in the established master-planned community of Rocking ...

Today, the Government of Canada announced more than $40 million in contributions and low-cost repayable loans to build and repair 149 homes through eight housing projects located in Northern ...

Two new studies led by researchers at Hospital for Special Surgery (HSS) have uncovered key biological mechanisms driving systemic sclerosis (SSc), or ...

No writing assistance was utilized in the production of this manuscript. Plasmacytoid dendritic cells (pDCs) are specialized APCs. Compared with other APCs, pDCs express a high level of TLR9 and ...

“My research work unveiled that toll like receptor 7 and its major host cell, plasmacytoid dendritic cells are more abundant in females than males. Similarly, folate receptors which are very ...